showed a trendp =0.134
Patients with delayed surgical treatment offered neoadjuvant androgen deprivation therapy showed a trend towards a reduction in positive surgical margins ( p =0.134), N1 disease ( p =0.424) and pathological down-staging (50% patients with pT2 disease).